Teleflex Incorporated
Could not find a ticker for this position, may be a filing error
A maker of single-use medical devices for hospitals and healthcare providers worldwide, Teleflex sells vascular, interventional, and surgical products under brands like Arrow catheters, EZ-IO intraosseous systems, QuikClot hemostats, and MANTA closure devices. It operates through Americas, EMEA, and Asia segments and employs thousands of people globally. In 2025 it acquired BIOTRONIK's Vascular Intervention business, adding coronary and peripheral devices like drug-coated balloons and stents.
3.875% bond due 08/01/2017
Granted 82.9K · Bought 1.5K · Sold 26.3K
Granted 54.0K
Granted 17.0K
Granted 23.2K · Sold 14.0K
Granted 18.7K · Sold 7.4K
Granted 17.2K
Granted 17.0K
Granted 7.9K
Granted 22.4K · Bought 1.0K · Sold 2.7K
Granted 2.8K · Bought 1.0K
Granted 3.8K
Granted 2.8K · Bought 500
Granted 7.6K
Granted 1.7K
Granted 2.8K · Bought 1.5K
Granted 2.8K
Granted 1.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kelly LiamChairman, President & CEO, Director · 16 transactions | +63.7% | 64.6Kas of Aug 2025 | 82.9K | 1.5K | 26.3K |
| Weidman Jason R.President and CEO, Director · 1 transaction | — | 54.0K | 54.0K | — | — |
| Logue Daniel V.CVP, General Counsel & Secty · 15 transactions | +129.1% | 25.0K | 17.0K | — | — |
| Powell Thomas EExecutive Vice President & CFO · 14 transactions | +47.9% | 21.9Kas of Apr 2025 | 23.2K | — | 14.0K |
| Hicks Cameron PCorp. VP & Chief HR Officer · 14 transactions | +113.6% | 19.4K | 18.7K | — | 7.4K |
| Deren JohnExecutive Vice President & CFO · 12 transactions | +1030.3% | 18.1K | 17.2K | — | — |
| Winters JamesCorp VP, Mfg and Supply · 12 transactions | +642.5% | 17.8K | 17.0K | — | — |
| Klasko Stephen K. M.D.Director · 6 transactions | +38.3% | 17.2Kas of May 2025 | 7.9K | — | — |
| Randle Stuart ADirector · 10 transactions | +110% | 16.5K | 22.4K | 1.0K | 2.7K |
| Krakauer Andrew ADirector · 4 transactions | +85.8% | 8.3K | 2.8K | 1.0K | — |
| White JayCVP & Pres, Global Commercial · 6 transactions | +69% | 7.8Kas of Mar 2025 | 3.8K | — | — |
| Haggerty Gretchen RDirector · 5 transactions | +80.1% | 7.4K | 2.8K | 500 | — |
| Duncan Candace HDirector · 5 transactions | +74.2% | 7.0K | 7.6K | — | — |
| Heinmiller John CDirector · 2 transactions | +50.9% | 5.0Kas of May 2025 | 1.7K | — | — |
| Ryu JaewonDirector · 4 transactions | +814% | 4.8K | 2.8K | 1.5K | — |
| Patil Neena MDirector · 3 transactions | +301.3% | 3.7K | 2.8K | — | — |
| Tokich Michael JDirector · 1 transaction | — | 1.1K | 1.1K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -44.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.